Trial intelligence / Profile preview

N-acetylcysteine treatment in adults with cystic fibrosis and chronic Pseudomonas lung infection

2007-001401-15Phase 4Completed

Sponsor
Rigshospitalet
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of acetylcysteine in cystic fibrosis (CF), sponsored by Rigshospitalet. Primary endpoint: Oxidative stress markers. Started Apr 2010; status: completed.

02

Drugs

acetylcysteine
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on 2007-001401-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001401-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call